Caption Management’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-75,000
Closed -$2.54M 1942
2021
Q2
$2.54M Buy
+75,000
New +$1.91M 0.03% 596
2020
Q4
Sell
-26,864
Closed -$545K 1341
2020
Q3
$545K Sell
26,864
-6,136
-19% -$150K 0.01% 756
2020
Q2
$992K Buy
+33,000
New +$1.19M 0.03% 530

Caption Management's CNST Position: Q3 2021 in Review

Caption Management sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 75,000 shares — an estimated $2.54M sold.

Caption Management first reported a position in CNST in Q2 2020 and held it in 3 quarters. The position peaked at $2.54M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • Caption Management reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Caption Management sold 75,000 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $2.54M.
  • Caption Management first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2020 and held it in 3 quarters.
  • Caption Management's Constellation Pharmaceuticals, Inc. position peaked at $2.54M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Caption Management's 13F filing for Q3 2021, filed 12 Nov 2021.